A PYMNTS Company

FTC OKs Stryker’s Deal To Buy Wright Medical Group

By  |  November 3, 2020

Medical device maker Stryker has won US antitrust approval to buy Wright Medical Group on condition it sell certain assets, the Federal Trade Commission (FTC) announced on Tuesday, November 3.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The deal, which was valued at about US$4 billion when it was announced late last year, was part of a series of consolidations in the medical device industry and would make Stryker one of the market leaders in implants for the treatment of bone fractures as well joint replacements, reported Reuters.

    To win approval for the deal, the companies agreed that Stryker would sell its businesses that make total ankle replacements, generally used to treat arthritis, and finger joint implants, used to treat advanced arthritis, to DJO Global, the FTC stated.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.